Bluejay Diagnostics Statistics
Total Valuation
BJDX has a market cap or net worth of $941,820. The enterprise value is -$3.12 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BJDX has 554,012 shares outstanding.
| Current Share Class | 554,012 |
| Shares Outstanding | 554,012 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +175.69% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 6.76% |
| Float | 184,953 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.16 |
| P/TBV Ratio | 0.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.05, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.05 |
| Quick Ratio | 5.31 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.71 |
Financial Efficiency
Return on equity (ROE) is -178.98% and return on invested capital (ROIC) is -97.10%.
| Return on Equity (ROE) | -178.98% |
| Return on Assets (ROA) | -77.76% |
| Return on Invested Capital (ROIC) | -97.10% |
| Return on Capital Employed (ROCE) | -122.62% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.99M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.34% in the last 52 weeks. The beta is 0.35, so BJDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -99.34% |
| 50-Day Moving Average | 3.45 |
| 200-Day Moving Average | 7.53 |
| Relative Strength Index (RSI) | 38.64 |
| Average Volume (20 Days) | 3,396,799 |
Short Selling Information
The latest short interest is 38,307, so 6.91% of the outstanding shares have been sold short.
| Short Interest | 38,307 |
| Short Previous Month | 22,762 |
| Short % of Shares Out | 6.91% |
| Short % of Float | 20.71% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.17M |
| Pretax Income | -9.74M |
| Net Income | -20.94M |
| EBITDA | -7.09M |
| EBIT | -7.17M |
| Earnings Per Share (EPS) | -$114.19 |
Full Income StatementBalance Sheet
The company has $4.30 million in cash and $235,623 in debt, giving a net cash position of $4.07 million or $7.34 per share.
| Cash & Cash Equivalents | 4.30M |
| Total Debt | 235,623 |
| Net Cash | 4.07M |
| Net Cash Per Share | $7.34 |
| Equity (Book Value) | 5.73M |
| Book Value Per Share | 10.34 |
| Working Capital | 4.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.82 million and capital expenditures -$306,783, giving a free cash flow of -$8.13 million.
| Operating Cash Flow | -7.82M |
| Capital Expenditures | -306,783 |
| Free Cash Flow | -8.13M |
| FCF Per Share | -$14.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |